The
news coming out of medical conferences can be exciting for the MS
community. The results of clinical trials are often released at these
events. Snippets of groundbreaking research can be hidden in the
abstracts and poster presentations. Publicity surrounding research is
often considered good for scientists, their academic institutions, and
the MS community at large. Even if nothing comes of preliminary
research, it is beneficial to be able to see how that research had
developed over the years in retrospect. - See more at:
http://www.healthcentral.com/multiple-sclerosis/c/19065/163535/opinion-reporting#sthash.0t5EeWfO.dpuf
The
news coming out of medical conferences can be exciting for the MS
community. The results of clinical trials are often released at these
events. Snippets of groundbreaking research can be hidden in the
abstracts and poster presentations. Publicity surrounding research is
often considered good for scientists, their academic institutions, and
the MS community at large. Even if nothing comes of preliminary
research, it is beneficial to be able to see how that research had
developed over the years in retrospect. - See more at:
http://www.healthcentral.com/multiple-sclerosis/c/19065/163535/opinion-reporting#sthash.0t5EeWfO.dpuf
The
news coming out of medical conferences can be exciting for the MS
community. The results of clinical trials are often released at these
events. Snippets of groundbreaking research can be hidden in the
abstracts and poster presentations. Publicity surrounding research is
often considered good for scientists, their academic institutions, and
the MS community at large. Even if nothing comes of preliminary
research, it is beneficial to be able to see how that research had
developed over the years in retrospect. - See more at:
http://www.healthcentral.com/multiple-sclerosis/c/19065/163535/opinion-reporting#sthash.0t5EeWfO.dpuf
The news coming out of medical conferences can be exciting for the MS
community. The results of clinical trials are often released at these
events. Snippets of groundbreaking research can be hidden in the
abstracts and poster presentations. Publicity surrounding research is
often considered good for scientists, their academic institutions, and
the MS community at large. Even if nothing comes of preliminary
research, it is beneficial to be able to see how that research had
developed over the years in retrospect.
The
news coming out of medical conferences can be exciting for the MS
community. The results of clinical trials are often released at these
events. Snippets of groundbreaking research can be hidden in the
abstracts and poster presentations. Publicity surrounding research is
often considered good for scientists, their academic institutions, and
the MS community at large. Even if nothing comes of preliminary
research, it is beneficial to be able to see how that research had
developed over the years in retrospect. - See more at:
http://www.healthcentral.com/multiple-sclerosis/c/19065/163535/opinion-reporting#sthash.0t5EeWfO.dpuf
Read this post in its entirety:Opinion: Reporting on the "Not So Much News" News
Hi Lisa,
ReplyDeleteIt's good to see you again, even if it is with "not so much news" news. This story reminds me of what finally happened with 4-aminopyridine, a drug available from a compounding pharmacy for relatively little money (< $50). 4-AP was grabbed up by "Big Pharma, who tweaked with its molecules so that it would be available in a pill form thereby qualifying for its own patent, and released the drug as Ampyra. It is sold (two years ago when I tried it) for $1100 a month. There was very little R&D to be recouped so the reason for the egregious price hike can be summed up in one word: GREED.
I suspect the same will happen with dextromethorphan, which (also in my opinion) will offer minimal positive effects, just as 4-AP/Ampyra has.
Call me jaded, but I have watched this dance since 1981; I rarely read the latest medical news anymore. It's too depressing.